| Literature DB >> 27426012 |
Maria Odete Pereira Amaral1, António José de Almeida Garrido2, Carlos de Figueiredo Pereira3, Nélio Veiga Master4, Carla de Rosário Delgado Nunes5, Constantino Theodor Sakellarides5.
Abstract
OBJECTIVES: To determine the prevalence of insomnia in a sample of Portuguese adolescents and assess its repercussions on HRQoL, daytime sleepiness and depressive symptomatology.Entities:
Keywords: Adolescentes; Adolescents; Calidad de vida; Daytime sleepiness; Depressive symptoms; Insomnia; Insomnio; La somnolencia diurna; Los síntomas depresivos; Quality of life
Mesh:
Year: 2016 PMID: 27426012 PMCID: PMC6875964 DOI: 10.1016/j.aprim.2016.03.004
Source DB: PubMed Journal: Aten Primaria ISSN: 0212-6567 Impact factor: 1.137
Figure 1Study design.
Questions used to assess the presence of insomnia.
| Symptom type | Questions |
|---|---|
| Difficulty initiating sleep (DIS) | In the last month, did you have difficulty falling asleep at night? |
| Difficulty maintaining sleep (DMS) | In the last month, did you wake up during the night and have difficulty getting back to sleep? |
| Early morning awakening and difficulty getting back to sleep (EMA) | In the last month, did you wake up too early in the morning and have difficulty getting back to sleep |
| Non restorative sleep (NRS) | In the last month, did you feel your sleep to be restless, shoddy or superficial? |
| Impairment/daily life consequences | In the last month, did you wake up tired? |
Each question had four possible answers: Never;
Socio-demographic characteristics of the sample.
| Female | Male | Total | ||||
|---|---|---|---|---|---|---|
| % | % | % | ||||
| 3668 | 53.2 | 3231 | 46.8 | 6899 | 100.0 | |
| 12 | 372 | 10.2 | 340 | 10.6 | 712 | 10.4 |
| 13 | 540 | 14.8 | 482 | 15.0 | 1022 | 14.9 |
| 14 | 553 | 15.2 | 515 | 16.0 | 1068 | 15.6 |
| 15 | 621 | 17.1 | 579 | 18.0 | 1200 | 17.5 |
| 16 | 687 | 18.9 | 621 | 19.3 | 1308 | 19.1 |
| 17 | 642 | 17.6 | 460 | 14.3 | 1102 | 16.1 |
| 18 | 227 | 6.2 | 222 | 6.9 | 449 | 6.5 |
| 7th | 538 | 14.7 | 560 | 17.4 | 1098 | 15.9 |
| 8th | 575 | 15.7 | 539 | 16.7 | 1114 | 16.2 |
| 9th | 595 | 16.3 | 578 | 17.9 | 1173 | 17.0 |
| 10th | 710 | 19.4 | 650 | 20.1 | 1360 | 19.8 |
| 11th | 702 | 19.2 | 543 | 16.8 | 1245 | 18.1 |
| 12th | 539 | 14.7 | 357 | 11.1 | 896 | 13.0 |
| 0–4 | 456 | 12.8 | 382 | 12.2 | 838 | 12.5 |
| 5–6 | 1066 | 30.0 | 955 | 30.6 | 2021 | 30.2 |
| 7–12 | 1627 | 45.7 | 1409 | 45.1 | 3036 | 45.4 |
| >12 | 410 | 11.5 | 378 | 12.1 | 788 | 11.8 |
| Village | 2321 | 63.8 | 2017 | 63.3 | 4338 | 63.6 |
| Town | 911 | 25.0 | 783 | 24.6 | 1694 | 24.8 |
| City | 406 | 11.2 | 384 | 12.1 | 790 | 11.6 |
Health related quality of life (SF-36) and insomnia.
| Female | Male | |||||
|---|---|---|---|---|---|---|
| Insomnia | Normal sleepers | Insomnia | Normal sleepers | |||
| | 46.1 ± 11.0 | 50.1 ± 12.1 | <0.001 | 45.2 ± 13.3 | 50.6 ± 13.8 | <0.001 |
| | 38.4 ± 10.2 | 46.2 ± 10.6 | <0.001 | 41.0 ± 11.3 | 47.4 ± 11.6 | <0.001 |
| PF | 71.5 ± 21.8 | 73.1 ± 21.2 | 0.26 | 68.4 ± 27.6 | 73.8 ± 24.1 | 0.05 |
| RP | 6.9 ± 11.9 | 8.6 ± 12.0 | 0.03 | 6.4 ± 10.9 | 8.0 ± 11.8 | 0.14 |
| BP | 50.8 ± 20.7 | 55.6 ± 27.1 | <0.01 | 50.4 ± 26.2 | 56.3 ± 31.4 | 0.03 |
| GH | 55.4 ± 18.0 | 63.4 ± 17.5 | <0.001 | 55.7 ± 19.6 | 64.2 ± 20.2 | <0.001 |
| MH | 46.2 ± 14.9 | 58.7 ± 14.6 | <0.001 | 50.5 ± 15.7 | 60.9 ± 15.8 | <0.001 |
| RE | 0.7 ± 5.6 | 0.4 ± 5.0 | 0.41 | 0.3 ± 3.2 | 0.4 ± 5.0 | 0.85 |
| SF | 60.3 ± 21.1 | 69.1 ± 21.8 | <0.001 | 63.0 ± 23.9 | 68.7 ± 23.0 | 0.01 |
| VT | 46.2 ± 13.3 | 56.6 ± 14.3 | <0.001 | 50.3 ± 14.9 | 59.4 ± 15.7 | <0.001 |
Note: PH, Physical Health component; MH, Mental Health component; PF, physical functioning; RP, role-physical (role limitations due to physical problems); BP, bodily pain; GH, general health; MH, mental health; RE, role-emotional (role limitations due to emotional problems); SF, social functioning; VT, Vitality.
Daytime sleepiness and insomnia.
| Daytime sleepiness | |||
|---|---|---|---|
| Female | Male | Total | |
| OR (CI 95%) | OR (CI 95%) | OR (CI 95%) | |
| Normal sleep | 1 | 1 | 1 |
| Disturbed sleep | 1.30 (1.03–1.63) | 1.16 (0.83–1.62) | 1.29 (1.07–1.56) |
| Insomnia | 1.49 (1.14–1.95) | 2.54 (1.70–3.79) | 1.82 (1.45–2.27) |
Reference class.
Depressive symptoms (BDI-II) and insomnia.
| Female | Male | |||||
|---|---|---|---|---|---|---|
| Insomnia | Normal sleepers | Insomnia | Normal sleepers | |||
| AS | 5.6 ± 4.3 | 2.4 ± 2.8 | <0.001 | 4.6 ± 4.5 | 1.8 ± 2.8 | <0.001 |
| CS | 6.5 ± 5.1 | 3.4 ± 3.7 | <0.001 | 4.9 ± 4.5 | 2.3 ± 3.1 | <0.001 |
| SS | 6.8 ± 3.5 | 3.2 ± 3.0 | <0.001 | 5.8 ± 4.1 | 2.3 ± 3.1 | <0.001 |
Note: AS, affective symptoms; CS, cognitive symptoms; SS, somatic symptoms.